Botanical and Plant Derived Drugs Market, by Source (Plant, Algae, Macroscopic fungi, and Others), by Dosage Form (Pills, Tablets, Capsules, and Injection), by Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases,

Botanical and Plant Derived Drugs Market, by Source (Plant, Algae, Macroscopic fungi, and Others), by Dosage Form (Pills, Tablets, Capsules, and Injection), by Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), by Region - Global Forecast, 2022 - 2028

Botanical and plant derived drugs contain active ingredients derived from plants. The botanical drug is a mixture of plant materials that include whole plant, part of plants, fungi or algae. Plants have been used as a source of medicine since past, owing to side effects caused due to consumption of synthetic drugs the botanical and plant derived drugs are preferred over the synthetic drugs.
Furthermore, the botanical drugs are clinically evaluated for safety and efficacy just as conventional drugs. Besides, this legalization of medical cannabis is also expected to foster growth of the botanical and plant derived drugs market.
Market Dynamics
The global botanical and plant derived drugs market is projected to witness significant growth over the forecast period, owing to legalization of medical cannabis. Medical cannabis was legalized in the Czech Republic, in 2013, Argentina and Chile in 2015, and in 2016, marijuana legalization in America reached a tipping point, as the medical marijuana became legal in some of the states.
Hence, many manufacturers are focused on research and development on medical cannabis to launch new drugs. For instance, one of the drug by GW Pharmaceuticals, Epidiolex consists of cannabidivarin (CBDV) is in developmental process, which will be used in clinical trials for treatment resistant epilepsy, supported by NSW and Queensland government in 2016.
Furthermore, increasing number of chronic disease supports the growth of botanical and plant derived drugs, as lung cancer accounts for the leading cause of death in the Eastern, Southern and Southeastern Asia. The region holds for 56% of the world’s population and contributes to 44% of the total cancer cases worldwide according to the statistics mentioned in the Cancer Atlas.
.Key features of the study:
This report provides in-depth analysis of the Botanical and plant derived drugs market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global botanical and plant derived drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Concordia Pharmaceuticals, GW Pharmaceuticals, LEO Pharma, MEDICAGO, and Merck.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, market expansion, and marketing tactics.
The global botanical and plant derived drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for botanical and plant derived drugs market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
Global Botanical and Plant Derived Drugs Market, By Source:
Plant
Algae
Macroscopic fungi
Others
Global Botanical and Plant Derived Drugs Market, By Dosage Form:
Pills
Tablets
Capsules
Injection
Global Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Global Botanical and Plant Derived Drugs Market, By Region:
North America
North America Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
North America Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
North America Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
North America Botanical and Plant Derived Drugs Market, By Countries
U.S.
Canada
Europe
Europe Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
Europe Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
Europe Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Europe Botanical and Plant Derived Drugs Market, By Countries
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Asia Pacific Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
Asia Pacific Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
Asia Pacific Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Asia Pacific Botanical and Plant Derived Drugs Market, By Countries
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Latin America Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
Latin America Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
Latin America Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Latin America Botanical and Plant Derived Drugs Market, By Countries
Brazil
Mexico
Rest of Latin America
Middle East
Middle East Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
Middle East Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
Middle East Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Middle East Botanical and Plant Derived Drugs Market, By Countries
GCC
Israel
Rest of Middle East
Africa
Africa Botanical and Plant Derived Drugs Market, By Source
Plant
Algae
Macroscopic fungi
Others
Africa Botanical and Plant Derived Drugs Market, By Dosage Form
Pills
Tablets
Capsules
Injection
Africa Botanical and Plant Derived Drugs Market, By Therapeutic Application :
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Others
Africa Botanical and Plant Derived Drugs Market, By Countries
North Africa
Central Africa
South Africa
Company Profiles
Bayer Healthcare*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GlaxoSmithKline
Pfizer,Inc.
Sanofi
Actelion Pharmaceuticals
Aimil Pharmaceuticals
Allergan
AstraZeneca
Boehringer Ingelheim
GW Pharmaceuticals
“*” marked represents similar segmentation in other categories in the respective section.